Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
CorrectionCorrigenda
Open Access

Corrigenda

Anticancer Research August 2024, 44 (8) 3683-3694; DOI: https://doi.org/10.21873/anticanres.17193
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Vol. 44, No. 1, page 340, Table I should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Comparison of survival rates stratified by patient characteristics.

Vol. 44, No. 1, page 342, Table II should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Uni and Multivariate Cox proportional hazards analysis of clinicopathological factors for overall survival.

Vol. 44, No. 1, page 343, Table III should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Uni and Multivariate Cox proportional hazards analysis of clinicopathological factors for recurrence-free survival.

Vol. 44, No. 2, page 816, Table I should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Comparison of survival rates stratified by patient characteristics.

Vol. 44, No. 2, page 818, Table II should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Uni and Multivariate Cox proportional hazards analysis of clinicopathological factors for overall survival.

Vol. 44, No. 2, page 819, Table III should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Uni and Multivariate Cox proportional hazards analysis of clinicopathological factors for recurrence free survival.

Vol. 44, No. 5, page 2186, Table I should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Comparison of survival rates stratified by patient characteristics.

Vol. 44, No. 5, page 2189, Table II should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Uni and multivariate Cox proportional hazards analysis of clinicopathological factors for overall survival.

Vol. 44, No. 5, page 2190, Table III should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Uni and multivariate Cox proportional hazards analysis of clinicopathological factors for recurrence-free survival.

Vol. 44, No. 5, page 2232, Table I should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Comparison of survival rates stratified by patient characteristics.

Vol. 44, No. 5, page 2234, Table II should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Uni and Multivariate Cox proportional hazards analysis of clinicopathological factors for overall survival.

Vol. 44, No. 5, page 2235, Table III should read:

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Uni and Multivariate Cox proportional hazards analysis of clinicopathological factors for recurrence free survival.

Vol. 44, No. 7, page 2909, the last name of the sixth author should read:

ISSABAYEVA

Vol. 44, No. 7, page 2919, Authors’ Contributions, the first line should read:

KSO conceived the study; SHL, SAK, SJP, MYL, HWS, GI, JYH,

Vol. 44, No. 7, page 3149, the title of the article should read:

Predictive Factors for Early Biochemical Recurrence Following Robot-assisted Radical Prostatectomy

Vol. 44, No. 7, pages 3151 and 3153, the short running title of the article should read:

Predictive Factors for Early Recurrence After Robotic Prostatectomy

  • Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

PreviousNext
Back to top

In this issue

Anticancer Research: 44 (8)
Anticancer Research
Vol. 44, Issue 8
August 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Corrigenda
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Corrigenda
Anticancer Research Aug 2024, 44 (8) 3683-3694; DOI: 10.21873/anticanres.17193

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Corrigenda
Anticancer Research Aug 2024, 44 (8) 3683-3694; DOI: 10.21873/anticanres.17193
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Corrigenda
  • Corrigenda
  • Corrigenda
Show more Corrigenda
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire